SCHEMBL24475262

SCHEMBL24475262

c1ccc(-c2ccc3ccc4ccc(-c5cccc(-c6ccc7ccc8ccc(-c9ccc%10ccccc%10c9)nc8c7n6)c5)nc4c3n2)cc1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A1 P04798 1/20 0.57
CYP1B1 Q16678 1/20 0.57
PARP1 P09874 2/20 0.51
CYP1A2 P05177 4/20 0.47
CYP11B1 P15538 2/20 0.47
CYP11B2 P19099 2/20 0.47
CYP17A1 P05093 1/20 0.47
CYP19A1 P11511 1/20 0.47
RAB9A P51151 2/20 0.47
MEN1 O00255 2/20 0.47
KMT2A Q03164 2/20 0.47
HSD17B1 P14061 1/20 0.46
HSD17B2 P37059 1/20 0.46
ALDH1A1 P00352 3/20 0.45
SMN1; SMN2 Q16637 3/20 0.45
KDM4E B2RXH2 2/20 0.45
CYP2C9 P11712 1/20 0.45
HPGD P15428 1/20 0.45
CYP2C19 P33261 1/20 0.45
NPSR1 Q6W5P4 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21103767 0.98 CYP1A1 (0.56) CYP1A1CYP1B1PARP1CYP1A2CYP11B1
SCHEMBL21103674 0.97 CYP1A1 (0.54) CYP1A1CYP1B1PARP1CYP1A2CYP11B1
SCHEMBL10032275 0.96 CYP1A1 (0.51) CYP1A1CYP1B1PARP1CYP1A2CYP11B1
SCHEMBL10032315 0.95 CYP11B1 (0.53) CYP1A1CYP1B1PARP1CYP1A2CYP11B1
SCHEMBL21103640 0.93 CYP1A1 (0.49) CYP1A1CYP1B1PARP1CYP1A2CYP11B1
SCHEMBL21103678 0.93 CYP1A1 (0.49) CYP1A1CYP1B1PARP1CYP1A2CYP11B1
SCHEMBL17174050 0.93 CYP1A1 (0.55) CYP1A1CYP1B1PARP1CYP1A2CYP11B1
SCHEMBL10032247 0.93 CYP1A1 (0.55) CYP1A1CYP1B1PARP1CYP1A2CYP11B1
SCHEMBL19768133 0.92 CYP1A1 (0.58) CYP1A1CYP1B1PARP1CYP1A2CYP11B1
SCHEMBL19768118 0.92 CYP1A1 (0.58) CYP1A1CYP1B1PARP1CYP1A2CYP11B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220209131-A1 ORGANIC LIGHT EMITTING DIODE AND ORGANIC LIGHT EMITTING DEVICE INCLUDING THE SAME LG DISPLAY CO., LTD. (KR) 2022-06-30 US disclosed
US-20220209115-A1 ORGANIC LIGHT EMITTING DIODE AND ORGANIC LIGHT EMITTING DEVICE INCLUDING THE SAME LG DISPLAY CO., LTD. (KR) 2022-06-30 US disclosed
US-20220173323-A1 ORGANIC LIGHT EMITTING DIODE AND ORGANIC LIGHT EMITTING DEVICE HAVING THEREOF LG DISPLAY CO., LTD. (KR) 2022-06-02 US disclosed
US-20220173324-A1 ORGANIC LIGHT EMITTING DIODE AND ORGANIC LIGHT EMITTING DEVICE INCLUDING THE SAME LG DISPLAY CO., LTD. (KR) 2022-06-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220209131-A1 ORGANIC LIGHT EMITTING DIODE AND ORGANIC LIGHT EMITTING DEVICE INCLUDING THE SAME DDT, EML4, CRY1 CYP1A1 1171/4885CYP1B1 2150/4885PARP1 3916/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.